Comprehensive bioinformatics analysis of the E2F family in human clear cell renal cell carcinoma-Reference-Cited by-同舟云学术

Comprehensive bioinformatics analysis of the E2F family in human clear cell renal cell carcinoma

Published:2022-08-19 Issue:4 Volume:24 Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Liu Zhi-Guo¹,Su Jing²,Liu Hao³,Yang Xue-Jian³,Yang Xue⁴,Wei Ye⁵,Zhu Xin-Yao⁵,Song Yong⁶,Zhao Xian-Cheng³,Guo Hong-Lin⁷

Affiliation:

1. Department of Hospital Pharmacy, The Affiliated Suqian First People’s Hospital of Nanjing Medical University, Suqian, Jiangsu 223800, P.R. China

2. Department of Hematology, The Affiliated Suqian First People’s Hospital of Nanjing Medical University, Suqian, Jiangsu 223800, P.R. China

3. Department of Urinary Surgery, The Affiliated Suqian First People’s Hospital of Nanjing Medical University, Suqian, Jiangsu 223800, P.R. China

4. Department of Cardiology, The Affiliated Suqian First People's Hospital of Nanjing Medical University, Suqian, Jiangsu 223800, P.R. China

5. First Clinical Medical College, Xuzhou Medical University, Xuzhou, Jiangsu 221004, P.R. China

6. Institute of Preventive Medicine Information, Inspection and Protection, Hubei Provincial Center for Disease Control and Prevention, Wuhan, Hubei 430070, P.R. China

7. School of Public Administration, South Central University for Nationalities, Wuhan, Hubei 430074, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Reference30 articles.

1. Renal cell carcinoma: Diagnosis and management;Gray;Am Fam Physician,2019

2. The cancer genome atlas of renal cell carcinoma: Findings and clinical implications;Linehan;Nat Rev Urol,2019

3. Resistance to systemic therapies in clear cell renal cell carcinoma: Mechanisms and management strategies;Makhov;Mol Cancer Ther,2018

4. Metabolomic insights into pathophysiological mechanisms and biomarker discovery in clear cell renal cell carcinoma;Lucarelli;Expert Rev Mol Diagn,2019

5. Current and emerging first-line systemic therapies in metastatic clear-cell renal cell carcinoma;Tegos;J BUON,2019

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COL7A1 Expression Improves Prognosis Prediction for Patients with Clear Cell Renal Cell Carcinoma Atop of Stage;Cancers;2023-05-10

2. KNL1 is a prognostic and diagnostic biomarker related to immune infiltration in patients with uterine corpus endometrial carcinoma;Frontiers in Oncology;2023-01-27

3. COL7A1 expression improves prognosis prediction for patients with clear cell renal cell carcinoma atop of stage;2023-01-18